Rashmiranjan Mohanty\(^{1,*}\), Arpita Jena\(^{2}\) and Ranjan Kumar Mohanty\(^{3}\)
\(^{1}\)Assistant Professor, Department of Orthopedics, PRM Medical College, Baripada, Odisha, India.
\(^{2}\)Assistant Professor, Department of Anesthesiology, SCB Medical College Cuttack, Odisha, India.
\(^{3}\)Assistant Professor, Department of Cardiology, SCB Medical College, Cuttack, Odisha, India.
Objective: This study evaluated the efficacy and safety of perioperative intra-articular infiltration with a tranexamic acid and ropivacaine cocktail in patients undergoing bilateral total knee replacement (TKR). Methods: A randomized controlled trial was conducted involving 50 patients scheduled for elective bilateral TKR. Participants were randomly assigned to receive either intra-articular infiltration of a tranexamic acid and ropivacaine cocktail (intervention group) or standard care (control group). Outcome measures included postoperative blood loss, pain scores, range of motion, and adverse events. Results: Among the enrolled patients (n=50), the intervention group demonstrated reduced postoperative blood loss, evidenced by higher hemoglobin levels and lower drain output than the control group. Additionally, the intervention group exhibited consistently lower pain scores at various postoperative time points and greater improvements in range of motion. Conclusion: Intra-articular infiltration with a tranexamic acid and ropivacaine cocktail in bilateral TKR patients showed promising outcomes, including reduced blood loss, improved pain control, and enhanced range of motion. These findings suggest the potential of this adjunctive therapy in optimizing perioperative care for patients undergoing bilateral TKR. However, further research with larger sample sizes is warranted to validate these preliminary results and establish this intervention’s long-term efficacy and safety.
Copyright © 2023 the Author(s). This is an open access article distributed under the terms of the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0.
The Azerbaijan Pharmaceutical and Pharmacotherapy Journal (APPJ) aims to serve as a leading platform for the see more
From 2001 to 2021, the Azerbaijan Pharmaceutical and Pharmacotherapy Journal (APPJ) had a long-standing tradition of see more
Do you see an emerging area of research that needs to be highlighted? Or an existing research area that see more
Guest Editor: Dr. Kumaraswamy Gandla
Submission Deadline: 30 March 2024